Centiva Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
18,515
+8,352
| +82% | +$653K | 0.02% | 262 |
|
|
2025
Q1 | $737K | Buy |
10,163
+1,053
| +12% | +$76.3K | 0.02% | 487 |
|
|
2024
Q4 | $674K | Buy |
9,110
+4,641
| +104% | +$344K | 0.01% | 456 |
|
|
2024
Q3 | $295K | Buy |
+4,469
| New | +$295K | 0.01% | 1092 |
|
|
2024
Q2 | – | Sell |
-19,607
| Closed | -$1.87M | – | 1674 |
|
|
2024
Q1 | $1.87M | Buy |
19,607
+12,672
| +183% | +$1.21M | 0.05% | 206 |
|
|
2023
Q4 | $529K | Sell |
6,935
-16,118
| -70% | -$1.23M | 0.01% | 567 |
|
|
2023
Q3 | $1.6M | Buy |
23,053
+3,961
| +21% | +$274K | 0.04% | 239 |
|
|
2023
Q2 | $1.8M | Buy |
+19,092
| New | +$1.8M | 0.04% | 222 |
|
|
2022
Q4 | – | Sell |
-3,171
| Closed | -$262K | – | 991 |
|
|
2022
Q3 | $262K | Buy |
+3,171
| New | +$262K | ﹤0.01% | 669 |
|
|
2021
Q3 | – | Sell |
-3,988
| Closed | -$413K | – | 1018 |
|
|
2021
Q2 | $413K | Buy |
+3,988
| New | +$413K | 0.01% | 603 |
|
|
2020
Q4 | – | Sell |
-10,559
| Closed | -$843K | – | 767 |
|
|
2020
Q3 | $843K | Sell |
10,559
-4,040
| -28% | -$323K | 0.06% | 150 |
|
|
2020
Q2 | $1.01M | Buy |
+14,599
| New | +$1.01M | 0.06% | 89 |
|
|
2020
Q1 | – | Sell |
-9,462
| Closed | -$736K | – | 424 |
|
|
2019
Q4 | $736K | Buy |
+9,462
| New | +$736K | 0.04% | 125 |
|
|
2019
Q3 | – | Sell |
-1,662
| Closed | -$102K | – | 346 |
|
|
2019
Q2 | $102K | Buy |
+1,662
| New | +$102K | 0.01% | 130 |
|